CONTEXT: Epidemiologic studies have demonstrated that overweight/obese girls (OW/OB) undergo thelarche and menarche earlier than normal weight girls (NW). There have been no longitudinal studies to specifically investigate how body weight/fat affects both clinical and biochemical pubertal markers in girls. OBJECTIVE: To investigate the effect of total body fat on reproductive hormones and on the maturation of estrogen-sensitive tissues during puberty in girls. METHODS: Ninety girls (36 OW/OB, 54 NW), aged 8.2 to 14.7 years, completed 2.8 ± 1.7 study visits over 4 years. Visits included dual-energy x-ray absorptiometry to calculate total body fat (TBF), Tanner staging, breast ultrasound for morphological staging (BMORPH; A-E), pelvic ultrasound, hormone tests, and assessment of menarchal status. The effect of TBF on pubertal markers was determined using a mixed, multistate, or Cox proportional hazards model, controlling for baseline BMORPH. RESULTS: NW were older than OW/OB (11.3 vs 10.2 years, P < .01) at baseline and had more advanced BMORPH (P < .01). Luteinizing hormone, estradiol, and ovarian and uterine volumes increased with time with no effect of TBF. There was a time × TBF interaction for follicle-stimulating hormone, inhibin B, estrone, total and free testosterone, and androstenedione: Levels were initially similar, but after 1 year, levels increased in girls with higher TBF, plateaued in girls with midrange TBF, and decreased in girls with lower TBF. Girls with higher TBF progressed through BMORPH stage D more slowly but achieved menarche earlier than girls with lower TBF. CONCLUSION: In late puberty, girls with higher TBF demonstrate differences in standard hormonal and clinical markers of puberty. Investigation of the underlying causes and clinical consequences of these differences in girls with higher TBF deserves further study. Published by Oxford University Press on behalf of the Endocrine Society 2021.
CONTEXT: Epidemiologic studies have demonstrated that overweight/obese girls (OW/OB) undergo thelarche and menarche earlier than normal weight girls (NW). There have been no longitudinal studies to specifically investigate how body weight/fat affects both clinical and biochemical pubertal markers in girls. OBJECTIVE: To investigate the effect of total body fat on reproductive hormones and on the maturation of estrogen-sensitive tissues during puberty in girls. METHODS: Ninety girls (36 OW/OB, 54 NW), aged 8.2 to 14.7 years, completed 2.8 ± 1.7 study visits over 4 years. Visits included dual-energy x-ray absorptiometry to calculate total body fat (TBF), Tanner staging, breast ultrasound for morphological staging (BMORPH; A-E), pelvic ultrasound, hormone tests, and assessment of menarchal status. The effect of TBF on pubertal markers was determined using a mixed, multistate, or Cox proportional hazards model, controlling for baseline BMORPH. RESULTS: NW were older than OW/OB (11.3 vs 10.2 years, P < .01) at baseline and had more advanced BMORPH (P < .01). Luteinizing hormone, estradiol, and ovarian and uterine volumes increased with time with no effect of TBF. There was a time × TBF interaction for follicle-stimulating hormone, inhibin B, estrone, total and free testosterone, and androstenedione: Levels were initially similar, but after 1 year, levels increased in girls with higher TBF, plateaued in girls with midrange TBF, and decreased in girls with lower TBF. Girls with higher TBF progressed through BMORPH stage D more slowly but achieved menarche earlier than girls with lower TBF. CONCLUSION: In late puberty, girls with higher TBF demonstrate differences in standard hormonal and clinical markers of puberty. Investigation of the underlying causes and clinical consequences of these differences in girls with higher TBF deserves further study. Published by Oxford University Press on behalf of the Endocrine Society 2021.
Entities:
Keywords:
adolescent; body fat; neuroendocrine; obesity; puberty
Authors: Frank M Biro; Susan M Pinney; Bin Huang; Erin R Baker; Donald Walt Chandler; Lorah D Dorn Journal: J Clin Endocrinol Metab Date: 2014-07-16 Impact factor: 5.958
Authors: N H Birkebaek; A Lange; P Holland-Fischer; K Kristensen; S Rittig; H Vilstrup; A Handberg; H Gronbaek Journal: Eur J Endocrinol Date: 2010-09-09 Impact factor: 6.664
Authors: Frank M Biro; Bin Huang; Patricia B Crawford; Anne W Lucky; Ruth Striegel-Moore; Bruce A Barton; Stephen Daniels Journal: J Pediatr Date: 2006-02 Impact factor: 4.406
Authors: K O Klein; K A Larmore; E de Lancey; J M Brown; R V Considine; S G Hassink Journal: J Clin Endocrinol Metab Date: 1998-10 Impact factor: 5.958
Authors: Yee-Ming Chan; Margaret F Lippincott; James P Butler; Valerie F Sidhoum; Cindy X Li; Lacey Plummer; Stephanie B Seminara Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: Mark D Aupperlee; Yong Zhao; Ying Siow Tan; Yirong Zhu; Ingeborg M Langohr; Erin L Kirk; Jason R Pirone; Melissa A Troester; Richard C Schwartz; Sandra Z Haslam Journal: Breast Cancer Res Date: 2015-11-02 Impact factor: 6.466
Authors: Janet N Lucien; Madison T Ortega; Madison E Calvert; Cynthia Smith; Xiomara White; Heidi Rogers; Brittany Mosley; Ruhani Agrawal; Anna Drude; Christopher McGee; Margaret George; Audrey Brown; Kimberly Downey; Catherine Wild; Alexander Njunge; Cherie M Kuzmiak; David Zava; Theodore Zava; Jenny Pollard; Julie Francis; Breana L Beery; Margaret Harlin; Gladys Ruby Gonzalez; Natalie D Shaw Journal: J Pediatr Adolesc Gynecol Date: 2022-01-11 Impact factor: 2.046